文献速递儿童呼吸儿童感染

变应性支气管肺曲霉病对囊性纤维化儿童及青少年FEV1的影响:欧洲囊性纤维化学会患者登记分析

Effect of allergic bronchopulmonary aspergillosis on FEV1 in children and adolescents with cystic fibrosis: a European Cystic Fibrosis Society Patient Registry analysis.
PubMed 文献 · Arch Dis Child · 2017-03-21

该研究基于欧洲囊性纤维化学会患者登记系统2008-2010年纵向数据,纳入3350例6-17岁囊性纤维化患者,采用线性混合效应回归模型评估变应性支气管肺曲霉病(ABPA)对FEV1占预计值百分比的影响。结果显示,校正其他预后因素后,ABPA患者入组时FEV1仅比同龄无ABPA者低1.47个百分点(p=0.003),且后续随访中ABPA与年龄的交互作用不显著(p>0.05),未观察到ABPA相关的FEV1下降。结论提示,与常见临床认知不同,ABPA对年轻患者肺功能的影响在考虑其他预后因素后较为有限。

要点

  • 校正其他因素后,ABPA患者入组时FEV1仅比无ABPA者低1.47个百分点(p=0.003)。
  • 随访期间ABPA与年龄交互作用不显著(p>0.05),未发现ABPA相关FEV1下降。
  • 对11.82岁患者,FEV1影响因素按效应量降序为低BMI、高危基因型、女性、糖尿病、慢性铜绿假单胞菌感染和ABPA。

核心结论

  • 与ABPA严重损害肺功能的常见临床认知不同,校正其他预后因素后,年轻囊性纤维化患者伴与不伴ABPA的FEV1差异较小。

研究设计与样本

  • 纵向数据分析(2008-2010年),数据来自欧洲囊性纤维化学会患者登记系统,纳入3350例6-17岁患者,采用线性混合效应回归模型评估ABPA对FEV1占预计值百分比的影响。

主要发现

  • 2008年,ABPA患者(n=346)FEV1占预计值百分比均值(±SD)为78.6(±20.6),无ABPA者(n=2806)为88(±19.8)。
  • 校正其他变量后,ABPA患者入组时FEV1比同龄无ABPA者低1.47个百分点(p=0.003)。
  • 后续研究年份中ABPA与年龄的交互作用不显著(p>0.05),未观察到ABPA相关的FEV1下降。
  • 对于年龄11.82岁(人群平均年龄)的患者,2008年FEV1受影响最大的因素为低体重指数,其后依次为高危基因型(两个严重突变)、女性、糖尿病、慢性铜绿假单胞菌感染和ABPA(按效应量降序)。

临床怎么用

  • 临床应认识到,在考虑其他预后因素后,ABPA对年轻囊性纤维化患者FEV1的影响可能较传统认知温和,评估肺功能时需综合其他预后因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the effect of allergic bronchopulmonary aspergillosis (ABPA) on FEV1 percent predicted in children and adolescents with cystic fibrosis. DESIGN: Longitudinal data analysis (2008-2010). SETTING: Patients participating in the European Cystic Fibrosis Society Patient Registry. PARTICIPANTS: 3350 patients aged 6-17 years. MAIN OUTCOME MEASURE: FEV1 percent predicted was the main outcome measure (one measurement per year per child). To describe the effect of ABPA (main explanatory variable) on FEV1 while controlling for other prognostic factors, a linear mixed effects regression model was applied. RESULTS: In 2008, the mean (±SD) FEV1 percent predicted was 78.6 (±20.6) in patients with ABPA (n=346) and 88 (±19.8) in those without ABPA (n=2806). After considering other variables, FEV1 in subjects with ABPA on entry to the study was 1.47 percentage points lower than FEV1 in patients of similar age without ABPA (p=0.003). There was no FEV1 decline associated with ABPA over the subsequent study years as the interaction of ABPA with age was not significant (p>0.05). For patients aged 11.82 years (population mean age), poor body mass index had the greatest impact on FEV1 in 2008, followed by high-risk genotype (two severe mutations), female gender, diabetes mellitus, chronic Pseudomonas aeruginosa infection and ABPA in descending order of effect size. CONCLUSIONS: In contrast to the common clinical belief of ABPA having a serious impact on lung function, the difference in FEV1 between young patients with and without the complication was found to be modest when the effect of other prognostic factors was considered.

来源:Arch Dis Child,查看原文。版权归原作者所有。

引用

  1. Kaditis AG, Miligkos M, Bossi A, et al. Effect of allergic bronchopulmonary aspergillosis on FEV1 in children and adolescents with cystic fibrosis: a European Cystic Fibrosis Society Patient Registry analysis. Arch Dis Child. 2017. PMID: 28325727. doi:10.1136/archdischild-2016-311132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。